Detalles de la búsqueda
1.
Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease.
Proteome Sci
; 16: 13, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29983642
2.
Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease.
Proteome Sci
; 16: 4, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29456458
3.
QSSPN: dynamic simulation of molecular interaction networks describing gene regulation, signalling and whole-cell metabolism in human cells.
Bioinformatics
; 29(24): 3181-90, 2013 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24064420
4.
Protectiveness of NAM-based hazard assessment - which testing scope is required?
ALTEX
; 41(2): 302-319, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048429
5.
A systems approach reveals species differences in hepatic stress response capacity.
Toxicol Sci
; 196(1): 112-125, 2023 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37647630
6.
Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease.
NPJ Syst Biol Appl
; 4: 33, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30131870
7.
Integration of Genome Scale Metabolic Networks and Gene Regulation of Metabolic Enzymes With Physiologically Based Pharmacokinetics.
CPT Pharmacometrics Syst Pharmacol
; 6(11): 732-746, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28782239
8.
Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease.
World J Gastroenterol
; 20(41): 15070-8, 2014 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25386055
Resultados
1 -
8
de 8
1
Próxima >
>>